Cervomed Inc (CRVO) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Cervomed Inc (CRVO) following the 2026 Q2 hedge fund 13F filings?

As of today, CRVO has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), CRVO gained -11.9% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Cervomed Inc (CRVO)

36 + Investors. Track Smart Money conviction in CRVO. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — CRVO

Based on 36 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds reduced or closed their CRVO positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

📊

High ownership — 75% of 3.0Y peak

75% of all-time peak

36 funds currently hold this stock — 75% of the 3.0-year high of 48 funds (reached 2024 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

📉

Outflows — 20% fewer funds vs a year ago

fund count last 6Q

9 fewer hedge funds hold CRVO compared to a year ago (-20% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.

🟠

More sellers than buyers — 43% buying

18 buying24 selling

Last quarter: 24 funds reduced or exited vs 18 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

➡️

Steady new buyers — ~8 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 10 → 14 → 10 → 8. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔄

Mostly new holders — 42% entered in last year

■ 17% conviction (2yr+) ■ 42% medium ■ 42% new

Only 6 funds (17%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💎

Buying through price weakness — shares -23%, value -69%

Value

-68%

-22%

Last quarter: funds added -23% more shares while total portfolio value only changed -69%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

📊

Peak discovery — momentum slowing

14 → 10 → 14 → 10 → 8 new funds/Q

New funds entering each quarter: 10 → 14 → 10 → 8. CRVO is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.

📊

Mixed cohorts — 19% veterans, 47% new entrants

■ 19% veterans ■ 33% 1-2yr ■ 47% new

Of 36 current holders: 7 (19%) held 2+ years, 12 held 1–2 years, 17 (47%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

🏆

Elite ownership — 63% AUM from top-100 funds

63% from top-100 AUM funds

11 of 36 holders are among the 100 largest funds by AUM, controlling 63% of total institutional value in CRVO. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

3.1

out of 10

Low Exit Risk

Exit risk score 3.1/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	36	47	-23.4%
13F Shares	2M	2M	-22.78%
Total Value	$7M	$22M	-68.61%
New Positions	8	10	-2
Increased Positions	10	13	-3
Closed Positions	19	5	+14
Reduced Positions	5	15	-10
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

-23.4%

13F Shares

-22.78%

Total Value

$7M

$22M

-68.61%

New Positions

-2

Increased Positions

-3

Closed Positions

+14

Reduced Positions

-10

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

36 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CRVO. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 CRVO holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Sabby Management, LLC	0.70%	248,880	$772K
2	Byrne Asset Management LLC	0.09%	51,250	$159K
3	Thompson Davis & CO., INC.	0.06%	29,750	$92K
4	Woodline Partners LP	0.01%	688,987	$2.1M
5	Savvy Advisors, Inc.	0.00%	25,922	$80K
6	Citizens Financial Group Inc/Ri	0.00%	37,477	$116K
7	NFSG Corp	0.00%	3,000	$9K
8	Summit Financial, LLC	0.00%	18,140	$56K
9	Hoey Investments, Inc	0.00%	1,080	$3K
10	Tower Research Capital LLC (TRC)	0.00%	2,173	$7K
11	Cetera Investment Advisers	0.00%	19,622	$61K
12	Russell Investments Group, Ltd.	0.00%	15,363	$48K
13	HighTower Advisors, LLC	0.00%	11,919	$37K
14	Vanguard Fiduciary Trust Co	0.00%	36,151	$112K
15	Vanguard Capital Management LLC	0.00%	316,202	$980K
16	SBI Securities Co., Ltd.	0.00%	255	—
17	Federation des caisses Desjardins du Quebec	0.00%	1,700	$5K
18	EverSource Wealth Advisors, LLC	0.00%	118	—
19	Caitong International Asset Management Co., Ltd	0.00%	27	—
20	Jane Street Group, LLC	0.00%	32,231	$100K
21	BlackRock, Inc.	0.00%	53,845	$167K
22	Nisa Investment Advisors, LLC	0.00%	251	—
23	Morgan Stanley	0.00%	12,699	$39K
24	Fmr LLC	0.00%	10,538	$33K
25	Citigroup Inc	0.00%	664	$2K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Cervomed Inc (CRVO)

What does the Smart Money Trend signal show for CRVO?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their CRVO positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for CRVO?

More sellers than buyers — 43% buying: Last quarter: 24 funds reduced or exited vs 18 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for CRVO holders?

Elite ownership — 63% AUM from top-100 funds: 11 of 36 holders are among the 100 largest funds by AUM, controlling 63% of total institutional value in CRVO. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held CRVO?

Mostly new holders — 42% entered in last year: Only 6 funds (17%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Cervomed Inc (CRVO) following the 2026 Q2 hedge fund 13F filings?

As of today, CRVO has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), CRVO has gained -11.9% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Cervomed Inc (CRVO)

Smart Money Signals — CRVO

Selling streak — 1 quarter in a row

High ownership — 75% of 3.0Y peak

Outflows — 20% fewer funds vs a year ago

More sellers than buyers — 43% buying

Steady new buyers — ~8 new funds per quarter

Mostly new holders — 42% entered in last year

Buying through price weakness — shares -23%, value -69%

Peak discovery — momentum slowing

Mixed cohorts — 19% veterans, 47% new entrants

Elite ownership — 63% AUM from top-100 funds

Institutional Sentiment Summary — CRVO

Hedge Fund Ownership: CRVO

Market Analysis: CRVO

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: CRVO

Is It Too Late to Buy Cervomed Inc (CRVO) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: CRVO

Statistics: CRVO

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Cervomed Inc (CRVO)

Welcome to 13Foresight!